Stocksigma LogoStocksigma Logo

Cohance Lifesciences Schedules Board Meeting on 6th Nov'26 for Q2/H1 Results

Cohance Lifesciences Limited has scheduled its Board of Directors meeting for 6th Nov'26 to consider and approve the standalone and consolidated unaudited

Cohance Lifesciences Schedules Board Meeting on 6th Nov'26 for Q2/H1 Results

Cohance Lifesciences Ltd 路 Intimation 路 06 Nov 2026, 5:30 am

Cohance Lifesciences Schedules Board Meeting on 6th Nov'26 for Q2/H1 Results Cohance Lifesciences Limited has scheduled its Board of Directors meeting for 6th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company's securities, which has been closed for designated persons and their immediate relatives since 28th Sep'26, will remain shut until 9th Nov'26.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements